Aurinia Pharmaceuticals Inc. (AUPH) vs Celldex Therapeutics, Inc. (CLDX)
A side-by-side comparison of Aurinia Pharmaceuticals Inc. and Celldex Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AUPH
Aurinia Pharmaceuticals Inc.
$15.51HealthcareDelayed quote: Oct 6, 2026, 10:40 AM EDT
CLDX
Celldex Therapeutics, Inc.
$31.39HealthcareDelayed quote: Oct 6, 2026, 10:40 AM EDT
Total return — AUPH vs CLDX
growth of $100 · dividends reinvested · last 10yAUPH +288.1% (+14.5%/yr)CLDX -49.1% (-6.5%/yr)AUPH compounded faster over this window
Log scale — wide-divergence pair
AUPH CLDX
AUPH vs CLDX: by the numbers
- •CLDX is the larger company ($2.09B vs $1.99B market cap).
- •AUPH is profitable (100.84% net margin) while CLDX runs a net loss (-268385.71%).
- •AUPH grew revenue faster over the past five years (40.17% vs -58.05% CAGR).
Metrics side by side
Valuation
| Metric | AUPH | CLDX |
|---|---|---|
| P/E ratio | 6.77 | N/A |
| Forward P/E | 16.43 | N/A |
| P/S ratio | 6.40 | 18645.62 |
| P/B ratio | 3.24 | 2.92 |
| EV / EBITDA | 11.02 | N/A |
| FCF yield | 8.70% | N/A |
Profitability
| Metric | AUPH | CLDX |
|---|---|---|
| Gross margin | 90.36% | 100.00% |
| Operating margin | 37.06% | -19160.00% |
| Net margin | 100.84% | -268385.71% |
| ROE | 51.09% | -42.07% |
| ROIC | 21.77% | -45.19% |
Growth (annualized)
| Metric | AUPH | CLDX |
|---|---|---|
| Revenue CAGR (5Y) | 40.17% | -58.05% |
| Total return CAGR (5Y) | -5.88% | -10.28% |
Frequently asked
- Which has grown faster, AUPH or CLDX?
- Over the past five years, AUPH grew revenue faster — AUPH at a 40.17% CAGR versus CLDX at -58.05%.
- Is AUPH or CLDX more profitable?
- AUPH runs the higher net margin — AUPH at 100.84% versus CLDX at -268385.71%.
- How have AUPH and CLDX total returns compared?
- Over the past 10 years, AUPH delivered 14.53% and CLDX delivered -6.79% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Aurinia Pharmaceuticals P/E ratioAurinia Pharmaceuticals ROECelldex Therapeutics ROEAurinia Pharmaceuticals operating marginCelldex Therapeutics operating marginAurinia Pharmaceuticals revenue growthCelldex Therapeutics revenue growthAurinia Pharmaceuticals free cash flowCelldex Therapeutics free cash flow
Aurinia Pharmaceuticals & Celldex Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.